Impaired baroreflex sensitivity as a potential marker of cardiovascular risk in hypertension.

Baroreflex heart rate control in hypertension Baroreflex mechanisms contribute importantly to shortterm regulation of heart rate, sympathetic tone and consequently blood pressure. The arterial baroreflex normally acts to oppose increases in blood pressure by inhibiting sympathetic activity, causing vasodilation and slowing heart rate. The traditional concept holds that arterial baroreflex is abnormal in hypertension [1,2], with a higher threshold for activation and a reduction in sensitivity; furthermore, these alterations result from chronic increases in arterial pressure. An important mechanism that allows sympathetic and arterial pressure to increase is baroreflex resetting [2]. Baroreflex resetting refers to a shift in the relationship between blood pressure changes and the efferent autonomic response (e.g. sympathetic nerve activity or heart rate). Sustained increases in pressure trigger a resetting of the operating point of the reflex to a higher level of pressure; that is, the baroreflex loses much of its ability to buffer the rise in pressure and actually functions to maintain pressure at the higher level. Hypertension-induced resetting of the baroreflex may be elicited by both ‘baroreceptor resetting’ (shift in pressure– afferent baroreflex activity relationship) and by ‘central resetting’ (shift in afferent baroreflex–efferent autonomic relationship) [3,4].

[1]  G Mancia,et al.  Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. , 1998, Hypertension.

[2]  V. Larrue,et al.  Baroreflex Sensitivity Is Impaired in Bilateral Carotid Atherosclerosis , 2005, Stroke.

[3]  R. J. Parmer,et al.  Baroreflex Sensitivity and Heredity in Essential Hypertension , 1992, Circulation.

[4]  F. Cambien,et al.  A polymorphism in the endothelin-A receptor gene is linked to baroreflex sensitivity , 2005, Journal of hypertension.

[5]  G. Parati,et al.  How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life , 2000, Journal of hypertension.

[6]  Hélène Pierre,et al.  EVAluation of the prognostic value of BARoreflex sensitivity in hypertensive patients: the EVABAR study , 2008, Journal of hypertension.

[7]  J. Bigger,et al.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction , 1998, The Lancet.

[8]  G. Mancia,et al.  Baroreceptor control of the circulation in man. An update. , 1995, Clinical and experimental hypertension.

[9]  G. Mancia,et al.  Structural cardiovascular adaptation and the consequences for baroreflexes. , 1984, Hypertension.

[10]  O. A. Álvarez,et al.  Heart capillary permeability to lipid‐insoluble molecules , 1969, The Journal of physiology.

[11]  N. Pandian,et al.  Baroreflex sensitivity correlates with left ventricular morphology and diastolic function in essential hypertension , 2007, Journal of hypertension.

[12]  G. Grassi Cardiovascular and sympathetic effects of reversing insulin resistance in hypertension. , 2004, Journal of hypertension.

[13]  A. J. Honour,et al.  Diminished baroreflex sensitivity in high blood pressure and ageing man. , 1969, Journal of Physiology.

[14]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[15]  R. Rea,et al.  Baroreflex control of muscle sympathetic nerve activity in borderline hypertension. , 1990, Circulation.

[16]  V. Somers,et al.  Arterial baroreflex function and cardiovascular variability: interactions and implications. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[17]  T. Giles,et al.  Circadian rhythm of blood pressure and the relation to cardiovascular events , 2006, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[18]  G. Grassi Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: Rationale and options , 2003, Current hypertension reports.

[19]  Mats Johansson,et al.  Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure , 2007, Journal of hypertension.

[20]  M. Joyner,et al.  Baroreflex Sensitivity Inversely Correlates With Ambulatory Blood Pressure in Healthy Normotensive Humans , 2007, Hypertension.

[21]  A. Porta,et al.  Analysis of Heart Period and Arterial Pressure Variability in Childhood Hypertension: Key Role of Baroreflex Impairment , 2008, Hypertension.

[22]  G. Mancia,et al.  Baroreflex function in hypertension: consequences for antihypertensive therapy. , 2006, Progress in cardiovascular diseases.

[23]  G. Parati,et al.  Mechanical and neural components of the cardiac baroreflex: new insights into complex physiology , 2005, Journal of hypertension.